Predictions
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
08.07.21
08.07.21
-
08.07.22
08.07.22
-80.73%
21.05.22
21.05.22
Pieris Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.94
08.07.21
08.07.21
-
08.07.22
08.07.22
-43.91%
21.05.22
21.05.22
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€71.40
08.07.21
08.07.21
-
08.07.22
08.07.22
-69.54%
21.05.22
21.05.22
Plug Power Inc.
Start price
Target price
Perf. (%)
€22.23
18.05.21
18.05.21
€28.00
18.05.22
18.05.22
-32.83%
19.05.22
19.05.22
Fair valuation
Sustainability is important
EBIT growth >5% per year expected
Very low/no dividend yield expected
Kulicke & Soffa Industries Inc.
Start price
Target price
Perf. (%)
€39.40
18.05.21
18.05.21
€49.00
18.05.22
18.05.22
18.27%
19.05.22
19.05.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Calithera Biosciences Inc.
Start price
Target price
Perf. (%)
€35.80
17.05.21
17.05.21
-
17.05.22
17.05.22
-88.46%
18.05.22
18.05.22
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€37.24
16.11.21
16.11.21
-
19.12.25
19.12.25
-61.86%
16.05.22
16.05.22
Could be worthwhile Investment >10% per year
Vertex Energy Inc.
Start price
Target price
Perf. (%)
€10.49
12.05.22
12.05.22
€20.00
12.05.23
12.05.23
26.32%
16.05.22
16.05.22
Could be very worthwhile Investment >20% year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.00
06.05.22
06.05.22
-
06.05.23
06.05.23
-24.17%
15.05.22
15.05.22
Risky Investment
Overstock.com
Start price
Target price
Perf. (%)
€31.70
30.04.22
30.04.22
-
30.04.23
30.04.23
-9.16%
14.05.22
14.05.22
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€1.56
01.05.22
01.05.22
-
01.05.23
01.05.23
-24.58%
14.05.22
14.05.22
Risky Investment
Plug Power Inc.
Start price
Target price
Perf. (%)
€19.71
02.05.22
02.05.22
€25.00
02.05.23
02.05.23
-25.40%
14.05.22
14.05.22
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Marrone Bio Inn.
Start price
Target price
Perf. (%)
€1.13
30.04.22
30.04.22
€0.000
30.04.23
30.04.23
-18.58%
14.05.22
14.05.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Zosano Pharma Corp.
Start price
Target price
Perf. (%)
€1.43
02.05.22
02.05.22
€1.00
02.05.23
02.05.23
18.02%
05.05.22
05.05.22
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
Netlist Inc.
Start price
Target price
Perf. (%)
€1.79
04.05.21
04.05.21
-
04.05.22
04.05.22
119.80%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€52.93
11.04.22
11.04.22
€40.00
11.04.23
11.04.23
4.10%
03.05.22
03.05.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Plug Power Inc.
Start price
Target price
Perf. (%)
€19.74
13.09.21
13.09.21
-
13.09.22
13.09.22
1.48%
02.05.22
02.05.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
Risky balance sheet
Lower EBIT Margin than peer group
Nathan S Famous
Start price
Target price
Perf. (%)
€52.00
01.05.21
01.05.21
€70.00
01.05.22
01.05.22
-15.00%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Pra Group Inc
Start price
Target price
Perf. (%)
€31.20
01.05.21
01.05.21
€33.00
01.05.22
01.05.22
27.56%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
21.04.22
21.04.22
-
21.04.23
21.04.23
4.15%
01.05.22
01.05.22
Risky Investment
Curis Inc.
Start price
Target price
Perf. (%)
€1.14
19.04.22
19.04.22
-
19.04.23
19.04.23
-21.19%
01.05.22
01.05.22
Risky Investment
Overstock.com
Start price
Target price
Perf. (%)
€35.46
17.04.22
17.04.22
-
17.04.23
17.04.23
-10.60%
30.04.22
30.04.22
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important